Analysis: Device makers should prioritize regulatory strategy

06/30/2009 | Medical Device & Diagnostic Industry

Medical-device firms seeking to bring their products to market should set up a regulatory strategy during the first phase of the product-development process, write Robert R. Andrews and Rosina Robinson in Medical Device & Diagnostic Industry. Companies also should effectively communicate with the FDA during the product-design phase, they write.

View Full Article in:

Medical Device & Diagnostic Industry

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL